Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1261033.RAKL-xrDt99ySC2GeQ8ynUioRIavSPY6yGv78_HxitMPI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1261033.RAKL-xrDt99ySC2GeQ8ynUioRIavSPY6yGv78_HxitMPI130_assertion type Assertion NP1261033.RAKL-xrDt99ySC2GeQ8ynUioRIavSPY6yGv78_HxitMPI130_head.
- NP1261033.RAKL-xrDt99ySC2GeQ8ynUioRIavSPY6yGv78_HxitMPI130_assertion description "[Thus, our results suggested that miR-362-3p or CD82 can be exploited as a new potential target for control of GC in the future.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1261033.RAKL-xrDt99ySC2GeQ8ynUioRIavSPY6yGv78_HxitMPI130_provenance.
- NP1261033.RAKL-xrDt99ySC2GeQ8ynUioRIavSPY6yGv78_HxitMPI130_assertion evidence source_evidence_literature NP1261033.RAKL-xrDt99ySC2GeQ8ynUioRIavSPY6yGv78_HxitMPI130_provenance.
- NP1261033.RAKL-xrDt99ySC2GeQ8ynUioRIavSPY6yGv78_HxitMPI130_assertion SIO_000772 25652145 NP1261033.RAKL-xrDt99ySC2GeQ8ynUioRIavSPY6yGv78_HxitMPI130_provenance.
- NP1261033.RAKL-xrDt99ySC2GeQ8ynUioRIavSPY6yGv78_HxitMPI130_assertion wasDerivedFrom befree-2016 NP1261033.RAKL-xrDt99ySC2GeQ8ynUioRIavSPY6yGv78_HxitMPI130_provenance.
- NP1261033.RAKL-xrDt99ySC2GeQ8ynUioRIavSPY6yGv78_HxitMPI130_assertion wasGeneratedBy ECO_0000203 NP1261033.RAKL-xrDt99ySC2GeQ8ynUioRIavSPY6yGv78_HxitMPI130_provenance.